Leadership Overview
Curium has 5 executives leading key functions including global strategy, regional operations, manufacturing, corporate development, and human capital management.
Driven by a commitment to nuclear medicine, Curium advances the development and manufacturing of radiopharmaceutical products to improve patient outcomes in oncology and beyond.
Driven by a commitment to nuclear medicine, Curium advances the development and manufacturing of radiopharmaceutical products to improve patient outcomes in oncology and beyond.
Leadership Roles at Curium
Tetiana George - Co-Founder & Chief Executive Officer
Tetiana George, the Co-Founder & Chief Executive Officer at Curium, directs the overarching vision for global radiopharmaceutical innovation. Overseeing the strategic trajectory of the organization, the Co-Founder & Chief Executive Officer ensures that research and development efforts align with the mission to provide world-class diagnostic and therapeutic solutions. This leadership role involves managing complex international manufacturing networks while fostering partnerships that expand the reach of nuclear medicine. By prioritizing investment in cutting-edge technologies, Tetiana George drives the company toward a future beyond cancer. The Co-Founder & Chief Executive Officer maintains rigorous standards for quality and safety across all global facilities. Through constant evaluation of market trends and clinical needs, the Co-Founder & Chief Executive Officer secures the long-term viability of the product pipeline. Ultimately, George shapes the corporate culture to emphasize patient-centric care and scientific excellence.
Michael Patterson - Chief Executive Officer, Curium (North America)
Michael Patterson, the Chief Executive Officer, Curium (North America) at Curium, manages all regional operations and commercial activities across the North American market. Overseeing the distribution of radiopharmaceutical products, the Chief Executive Officer, Curium (North America) ensures that healthcare providers receive critical diagnostic tools with maximum efficiency. This leadership role involves navigating complex regulatory landscapes and optimizing supply chain logistics to meet the high demand for oncology treatments. By scaling regional infrastructure, Michael Patterson directly impacts the availability of life-saving therapies for patients throughout the continent. The Chief Executive Officer, Curium (North America) collaborates with clinical partners to identify emerging needs in nuclear diagnostics. Through strategic resource allocation, Patterson strengthens the market position of the company within the competitive pharmaceutical sector. Ultimately, the Chief Executive Officer, Curium (North America) delivers consistent operational growth while maintaining strict adherence to safety protocols.
Simon Yin - Lead Senior Director, Strategy & To The Chief of Staff & Chief Executive Officer
Simon Yin, the Lead Senior Director, Strategy & To The Chief of Staff & Chief Executive Officer at Curium, architects the long-term strategic initiatives and coordinates executive decision-making processes. Overseeing the alignment of corporate goals with daily business activities, the Lead Senior Director, Strategy & To The Chief of Staff & Chief Executive Officer facilitates communication between the C-suite and various departments. This leadership role involves analyzing market data to identify growth opportunities in nuclear diagnostics and therapies. By managing high-priority projects, Simon Yin ensures that the organization remains agile in a rapidly evolving pharmaceutical landscape. The Lead Senior Director, Strategy & To The Chief of Staff & Chief Executive Officer supports the executive team by providing actionable insights and streamlining internal workflows. Through meticulous planning and execution, Yin drives the implementation of strategic programs that enhance the company's competitive advantage. Ultimately, the Lead Senior Director, Strategy & To The Chief of Staff & Chief Executive Officer fosters organizational cohesion.

James Portwood - Chief Operating Officer
James Portwood, the Chief Operating Officer at Curium, directs the global manufacturing and supply chain functions to ensure seamless production of radiopharmaceuticals. Overseeing the daily operations of production facilities, the Chief Operating Officer maintains the integrity of the manufacturing process from raw material procurement to final product delivery. This leadership role involves implementing advanced automation and process improvements to increase output capacity and operational efficiency. By coordinating cross-functional teams, James Portwood ensures that the company meets global demand for diagnostic and therapeutic agents. The Chief Operating Officer monitors performance metrics to identify bottlenecks and optimize resource utilization across all sites. Through rigorous oversight of technical standards, Portwood guarantees that every product meets the highest quality benchmarks. Ultimately, the Chief Operating Officer supports the broader corporate mission by ensuring that the supply chain remains resilient and capable of scaling to meet future clinical requirements.
Marla Franz - Global Chief People Officer
Marla Franz, the Global Chief People Officer at Curium, directs the human capital strategy to attract, develop, and retain top-tier talent across the global organization. Overseeing the implementation of comprehensive talent management programs, the Global Chief People Officer ensures that the workforce possesses the specialized skills required for advanced radiopharmaceutical manufacturing. This leadership role involves cultivating a culture of innovation and inclusivity that supports the company's mission to improve patient lives. By designing competitive compensation and professional development frameworks, Marla Franz drives employee engagement and organizational performance. The Global Chief People Officer collaborates with leadership to align workforce capabilities with the strategic objectives of the business. Through the promotion of wellness and safety initiatives, Franz maintains a high-performing environment across all international regions. Ultimately, the Global Chief People Officer secures the human resources necessary to sustain long-term growth and scientific advancement within the pharmaceutical industry.
Explore Leadership Teams in Manufacturing
AbbVie Inc. is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines and health solutions that address some of the worlds most complex medical challenges. Headquartered in North Chicago, Illinois, the company operates internationally and focuses on advancing treatments that improve patient outcomes and overall quality of life. AbbVies scientific and commercial efforts are concentrated in several core therapeutic areas, including immunology, oncology, neuroscience, eye care, and medical aesthetics, along with other specialty areas where significant unmet medical needs exist. Through these focus areas, the company works to create therapies that help patients manage chronic, serious, and often life-altering diseases.
Company Leadership BG
MS
Founded and headquartered in Darmstadt, Germany, Merck KGaA is a multinational pharmaceutical, chemical and life sciences company. Merck operates in Europe, Africa, Asia, Oceania and the Americas. It has major research and development centres in Darmstadt, Boston, Tokyo and Beijing.
Company Leadership CO
Founded in 2001 and headquartered in Moscow, Russia, R-Pharm is a pharmaceutical company. The company is involved in R&D, manufacturing (finished dosage forms, biotech and chemical APIs), marketing, sales and distribution of innovative pharmaceutical products in hospital/specialty care therapeutic areas.
Company Leadership OB
AS
BO
21st Century Vitamins operates as a globally recognized manufacturer and distributor of dietary supplements, positioned within the broader health and wellness industry. The company, through its parent entity 21st Century HealthCare, Inc., focuses on developing, producing, and delivering a wide range of vitamins, minerals, herbal supplements, and specialty nutritional products designed to support everyday health and well-being. With a history spanning more than three decades, the organization has established itself as a trusted and accessible brand in the consumer healthcare market. At its core, the company functions as both a manufacturer and a direct-to-consumer wellness provider. It produces an extensive portfolio of dietary supplements that cater to diverse health needs, including general nutrition, immune support, cardiovascular health, digestive wellness, sports nutrition, and beauty supplements. Its offerings range from traditional multivitamins and single-nutrient formulations to advanced blends such as amino acids, probiotics, and plant-based supplements. This breadth of product categories reflects the companys strategy of addressing a wide spectrum of consumer health requirements through scientifically formulated solutions.
Company Leadership SS
FC
KW